Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Capturing data on colostomy formation in anal cancer
Rob Glynne-Jones, Sandy Beare, Rubina Begum, et al.
Clinical Trials (London, England)
|
April 25, 2023
Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri
Adam R Brentnall, Chris Mathews, Sandy Beare, et al.
The Lancet. Oncology
|
February 18, 2017
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
Robert Glynne-Jones, David Sebag-Montefiore, Helen M Meadows, et al.
Journal of Medical Imaging and Radiation Oncology
|
May 16, 2020
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer
Anne Miles, Ruth Ec Evans, Steve Halligan, et al.
European Radiology
|
April 3, 2019
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment
Anne Miles, Stuart A Taylor, Ruth E C Evans, et al.
ESMO Open
|
August 11, 2018
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer
Stephen P Pereira, Mark Jitlal, Marian Duggan, et al.
Health Technology Assessment (Winchester, England)
|
December 20, 2019
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
Stuart A Taylor, Susan Mallett, Anne Miles, et al.
British Journal of Cancer
|
September 1, 2017
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
Simon Gollins, Nick West, David Sebag-Montefiore, et al.
The Lancet. Oncology
|
September 9, 2017
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Beatrice Seddon, Sandra J Strauss, Jeremy Whelan, et al.
BMC Cancer
|
May 4, 2017
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)
Stuart A Taylor, Sue Mallett, Anne Miles, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Capturing data on colostomy formation in anal cancer
Rob Glynne-Jones, Sandy Beare, Rubina Begum, et al.
Clinical Trials (London, England)
|
April 25, 2023
Dynamic data-enabled stratified sampling for trial invitations with application in NHS-Galleri
Adam R Brentnall, Chris Mathews, Sandy Beare, et al.
The Lancet. Oncology
|
February 18, 2017
Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
Robert Glynne-Jones, David Sebag-Montefiore, Helen M Meadows, et al.
Journal of Medical Imaging and Radiation Oncology
|
May 16, 2020
Predictors of patient preference for either whole body magnetic resonance imaging (WB-MRI) or CT/ PET-CT for staging colorectal or lung cancer
Anne Miles, Ruth Ec Evans, Steve Halligan, et al.
European Radiology
|
April 3, 2019
Patient preferences for whole-body MRI or conventional staging pathways in lung and colorectal cancer: a discrete choice experiment
Anne Miles, Stuart A Taylor, Ruth E C Evans, et al.
ESMO Open
|
August 11, 2018
PHOTOSTENT-02: porfimer sodium photodynamic therapy plus stenting versus stenting alone in patients with locally advanced or metastatic biliary tract cancer
Stephen P Pereira, Mark Jitlal, Marian Duggan, et al.
Health Technology Assessment (Winchester, England)
|
December 20, 2019
Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
Stuart A Taylor, Susan Mallett, Anne Miles, et al.
British Journal of Cancer
|
September 1, 2017
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutations
Simon Gollins, Nick West, David Sebag-Montefiore, et al.
The Lancet. Oncology
|
September 9, 2017
Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial
Beatrice Seddon, Sandra J Strauss, Jeremy Whelan, et al.
BMC Cancer
|
May 4, 2017
Streamlining staging of lung and colorectal cancer with whole body MRI; study protocols for two multicentre, non-randomised, single-arm, prospective diagnostic accuracy studies (Streamline C and Streamline L)
Stuart A Taylor, Sue Mallett, Anne Miles, et al.
Page
of 2